SCHEMBL7577238

SCHEMBL7577238

O=C(Nc1cccc2ccccc12)N1CCCC(CCNc2nccc(-n3cnc4cc(-c5ccncc5)ccc43)n2)C1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7506504 0.90 LCK (0.60) LCK
SCHEMBL7505858 0.90 LCK (0.55) LCK
SCHEMBL7876873 0.88 LCK (0.75) LCK
SCHEMBL7506774 0.85 LCK (0.57) LCK
SCHEMBL7569953 0.85 LCK (0.81) LCK
SCHEMBL7514593 0.83 LCK (0.54) LCK
SCHEMBL7508987 0.83 LCK (0.73) LCK
SCHEMBL7512300 0.83 LCK (0.69) LCK
SCHEMBL7506397 0.81 LCK (0.59) LCK
SCHEMBL7507725 0.81 LCK (0.57) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206260-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-10-30 EP disclosed
EP-1206260-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000207-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed